Maryland biotech Salubris Biotherapeutics clinches $35M investment for R&D


The new capital brings Salubris Biotherapeutics' lifetime funding to more than $100 million.

Previous Digital Media Solutions shores up its balance sheet with $14M capital raise
Next Here are Dallas' 15 best spots for coffee, according to Tripadvisor